4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001387131-17-001184
CIK 0000887247operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:04 PM ET
Size
6.1 KB
Accession
0001387131-17-001184
Insider Transaction Report
Form 4
Moll Thomas
Vice President of Research
Transactions
- Award
Restricted Stock Units
2017-03-01+150,000→ 150,000 total→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock. The RSUs vest on the seventh anniversary of the grant date provided that the Reporting Person has continued to provide services to the Company during such period. The RSUs vest earlier in connection with a Change in Control of the Company (as defined in the Plan and the applicable award agreement) or upon the death or disability of the Reporting Person, and the shares covered by the RSU are issuable following vesting as provided in the Plan and the applicable award agreement. The RSUs are granted pursuant to the Company's 2009 Equity Incentive Plan (the "Plan") and are subject to other provisions in the applicable award agreement.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:04 PM ET
- Size
- 6.1 KB